MIT Drug Cuts Lung Cancer Risk in Early Trials

MIT researchers discovered that blocking a single inflammatory enzyme dramatically reduces lung tumor formation in mice, opening the door to preventing cancer before it starts.

The drug is already in clinical trials for other diseases.